High Intensity Training in Patients With Facioscapulohumeral Muscular Dystrophy (HIT-FSHD)

High Intensity Interval Training in Patients With Facioscapulohumeral Muscular Dystrophy

The investigators aim to investigate the effect of high-intensity training in patients with facioscapulohumeral muscular dystrophy. Can patients benefit from this type of exercise without muscle damage.

Study Overview

• Status: Completed
• Conditions: FSHD - Facioscapulohumeral Muscular Dystrophy
• Intervention / Treatment: Other: Supervised training; Other: Optional training; Other: Unsupervised training; Other: Control

Detailed Description

Clinical trials have in recent years demonstrated that aerobic exercise, are both effective and safe in patients with facioscapulohumeral muscular dystrophy. Previous studies have tested exercise at moderate intensity. No studies have so far investigated whether high-intensity-training (HIIT) exercise can increase fitness, or the training will cause muscle damage. However, we know that patients with facioscapulohumeral muscular dystrophy do not get increased muscle damage after a single exercise at high intensity.

Investigators aim to investigate whether patients with facioscapulohumeral muscular disease may increase their fitness and improve their functioning in everyday life without muscle injury in a time-saving high intensity training.

To investigate whether HIIT is safe and effective, three groups of participants are included. Two training groups, one group of patients and another with healthy matched subjects. The training is done on an ergometer-bike three times a week for 8 weeks. One weekly training will be supervised. The training consists of an interval training program (10-20-30). The third group is a none-training control group of patients. This group will undergo the same tests as the two training groups.

To investigate wether participants would continue HIIT training after 8 weeks of supervised training, the two training groups, one group of patients and one group of healthy matched subjects, are tested after additional 8 weeks of home based optional training.

To investigate wether patients with muscular dystrophy facioscapulohumeral will perform unsupervised HIIT training and whether it will be as effective as the supervised training, the control group of patients who did not train the first 8 weeks, is instructed to do home based HIIT for 8 weeks.

• Study Type: Interventional
• Enrollment (Actual): 18
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Denmark
  • Copenhagen, Denmark, DK-2100
    • Copenhagen Neuromuscular Center, Department of Neurology, Rigshospitalet

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 70 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Diagnosed with Facioscapulohumeral muscular dystrophy or
• healthy matched control, matched for age, gender, BMI and activity level.

Exclusion Criteria:

• More than 1 hour cardiac exercise weekly before inclusion.
• Pregnant or breastfeeding women.
• Physical or mental condition, which could influence the results.
• Participating in other studies, which could influence the results.
• Physical or mental condition, which prevent participating in the study protocol.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Supportive Care
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Supervised training; 8 weeks of high intensity training three times a week, once supervised. Followed by 8 weeks home based, unsupervised optional training.	Other: Supervised training; 8 weeks high intensity interval training, 3 times a week, one is supervised, two are home based unsupervised.; Other: Optional training; 8 weeks of optional home based, unsupervised training.
Experimental: Unsupervised training; Participants have 8 weeks of non-intervention "Control" period, followed by 8 weeks of home based, unsupervised high intensity interval training.	Other: Unsupervised training; 8 weeks home based high-intensity-interval cycle-training 3 times a week.; Other: Control; 8 weeks of control period. Participants are doing daily living.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Incremental test	An incremental test is performed at baseline (week 1), after 4 weeks interval training, in the end of 8 weeks interval training, and after another 8 week of individual home based training. The primary outcome is change from baseline in maximal oxygen consumption and work load.	week 1,6,11 and 18

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Physical function	We measure changes from baseline in muscle strength, walking speed and the ability to rise up from a chair. Muscle strength is measured by a hand-held dynamometer. Walking speed is measured by a 6 minute walk test. The ability to rise up from a chair is measured by a 5-times-sit-to-stand-test.	baseline, week 6,11 and 18
Self-assessment	Changes between run-in period (week 1-2) and the first intervention period (week 3-11). Participants evaluate pain, muscle fatigue and daily activity level every day using a visual analog scale (VAS).	Every day in week 1-11
Creatine Kinase	Creatine Kinase (CK) is measure in plasma at week 1,6,11 and 18 in all participants. In the supervised training participants CK is also measured once a week doing the 8 weeks of supervised training.	week 1,6,11 and 18
Activity level	Change in activity level from baseline is measure as step/day. Participants is wearing a pedometer for seven days.	baseline, week 10 and week 18.

Collaborators and Investigators

• Sponsor: Grete Andersen, MD

Publications and helpful links

General Publications

• Andersen G, Hedermann G, Witting N, Duno M, Andersen H, Vissing J. The antimyotonic effect of lamotrigine in non-dystrophic myotonias: a double-blind randomized study. Brain. 2017 Sep 1;140(9):2295-2305. doi: 10.1093/brain/awx192.

Helpful Links

• The Neuromuscular research units web-side

Study record dates

Study Major Dates

• Study Start: June 1, 2014
• Primary Completion (Actual): September 1, 2015
• Study Completion (Actual): September 1, 2015

Study Registration Dates

• First Submitted: June 4, 2014
• First Submitted That Met QC Criteria: June 9, 2014
• First Posted (Estimate): June 10, 2014

Study Record Updates

• Last Update Posted (Estimate): April 25, 2016
• Last Update Submitted That Met QC Criteria: April 22, 2016
• Last Verified: April 1, 2016

More Information

Terms related to this study

• Keywords: Training; Exercise; FSHD; HIT; 10-20-30 interval training
• Additional Relevant MeSH Terms: Nervous System Diseases; Genetic Diseases, Inborn; Musculoskeletal Diseases; Muscular Diseases; Neuromuscular Diseases; Muscular Disorders, Atrophic; Muscular Dystrophies; Muscular Dystrophy, Facioscapulohumeral
• Other Study ID Numbers: H-4-2014-035 (FSH)